StonvexLoading…
StonvexCore line items from GLUE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $123.67M | $75.62M | $0.00 |
Operating Income | $-54.21M | $-81.11M | $-143.31M |
Net Income | $-38.63M | $-72.70M | $-135.35M |
EPS (Diluted) | $-0.46 | $-0.98 | $-2.63 |
Total Assets | $448.66M | $438.73M | $303.75M |
Total Liabilities | $215.60M | $215.80M | $124.50M |
Cash & Equivalents | $129.88M | $224.25M | $128.10M |
Free Cash Flow OCF − CapEx | $-27.50M | $38.01M | $-62.84M |
Shares Outstanding | 65.54M | 61.51M | 50.14M |